Eisler Capital (Us) LLC Axsome Therapeutics, Inc. Transaction History
Eisler Capital (Us) LLC
- $5.6 Trillion
- Q2 2024
A detailed history of Eisler Capital (Us) LLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Eisler Capital (Us) LLC holds 10,285 shares of AXSM stock, worth $932,849. This represents 0.01% of its overall portfolio holdings.
Number of Shares
10,285
Previous 9,046
13.7%
Holding current value
$932,849
Previous $722 Million
14.69%
% of portfolio
0.01%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding AXSM
# of Institutions
293Shares Held
40.3MCall Options Held
365KPut Options Held
423K-
Rtw Investments, LP New York, NY4.63MShares$420 Million6.23% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.74MShares$339 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$299 Million0.01% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA2.36MShares$214 Million37.71% of portfolio
-
Deep Track Capital, LP Greenwich, CT1.85MShares$168 Million4.89% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $3.89B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...